Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Teriparatide for Idiopathic Osteoporosis in Premenopausal Women
NCT01440803Phase 2Completed
- Start
- Aug 2012
- Primary completion
- Jan 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in idiopathic osteoporosis (IO) comparing Teriparatide with Placebo -> Teriparatide (2 arms). Primary endpoint: Change in Lumbar Spine Bone Mineral Density at 12 months. Started Aug 2012; status: completed.
02
Drugs
teriparatide
03
Conditions
idiopathic osteoporosis (IO)
Beyond the preview
Go deeper on NCT01440803.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01440803.